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Combined Ethylenediaminetetraacetic Acid Chelation, 
Phototherapeutic Keratectomy and Amniotic Membrane 
Transplantation for Treatment of Band Keratopathy
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Purpose: The objective of this study is to evaluate the therapeutic efficacy of ethylenediaminetetraacetic acid 
(EDTA) chelation and excimer laser phototherapeutic keratectomy (PTK) combined with amniotic membrane 
transplantation (AMT) for the treatment of band keratopathy (BK).
Methods: Eleven eyes in ten patients with BK received combined PTK (ablation zone of central 7.0-7.5 mm, depth 
of 50 µm), EDTA chelation (0.05 M, 3 minutes), and amniotic membrane transplantation using fibrin glue. Pre- 
and postoperative best corrected visual acuities, symptom changes, reepithelialization time, cosmesis, recurrence, 
and complications were analyzed. 
Results: Visual acuity improved in three eyes (27.3%) and did not change in eight eyes (72.7%). Symptoms im-
proved in all patients, and the mean reepithelialization time was 10.6±5.3 days. The cosmetic results were good 
in eight eyes (72.7%) and were fair in three eyes (27.3%). During the mean follow-up period of 11.4±6.1 months 
(range, 6 to 23 months), no postoperative complications or recurrences were observed. 
Conclusions: The combination of EDTA chelation, PTK, and AMT is safe and effective for the treatment of band 
keratopathy. 
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Band keratopathy (BK) is a chronic corneal degeneration 
characterized by the deposition of calcific materials throu- 
ghout the epithelium, basement membrane, Bowman’s layer, 
and superficial stroma. It may be associated with systemic 
conditions such as sarcoidosis or chronic renal failure or with 
chronic ocular inflammations such as chronic uveitis or 
long-standing interstitial keratitis [1,2].
The most widely used treatments for BK are ethyl-
enediaminetetraacetic acid (EDTA) chelation and super-
ficial keratectomy, which remove calcium deposits, restore 
the corneal surface, and improve ocular comfort [3-5].
 However, 
complete removal of deeply impacted calcium plaques in the 
anterior stroma is difficult with these conventional methods 
[6]. In addition, these procedures have several problems, in-
cluding severe pain, low visual acuity, long rehabilitation 
time, and recurrence after surgery [4-6].
 Phototherapeutic 
keratectomy (PTK) can be used to treat many corneal dis-
eases, including BK [7-10]. PTK is effective in treating path-
ologies at the deeper levels of Bowman’s layer and superficial 
stroma, which are not amenable to EDTA chelation or super-
ficial keratectomy. However, PTK also has shortcomings, 
such as postoperative pain and iatrogenic change in re-
fractive error [6-8]. 
The amniotic membrane (AM), which consists of a base-
ment membrane and stroma, contains many materials that fa-
cilitate corneal and conjunctival rehabilitation [11,12].
 
Amniotic membrane transplantation (AMT) has been widely 
used for ocular surface reconstruction as it facilitates epi-
thelialization while suppressing ocular surface inflammation, 
neovascularization, and scarring of the stroma [13-17].
 In ad-
dition, the amniotic membrane provides a mechanical band-
age that protects corneal wounds, absorbs inflammatory cy-
tokines, and reduces pain during corneal wound healing 
[13-15].
 This information has been used to develop treat-
ments for BK using a combination of surgical keratectomy 
with or without EDTA chelation followed by AMT [18,19].
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In the present study, we retrospectively investigated the 
therapeutic efficacy of EDTA chelation and excimer laser 
PTK combined with AMT for the treatment of BK found be-
neath the Bowman’s layer and in the anterior stroma.
Materials and Methods
Patients
We retrospectively reviewed the medical records of 11 
eyes of ten patients with BK involving the anterior stroma 
who underwent EDTA chelation and excimer laser PTK 
combined with AMT at Chonnam National University 
Hospital between January 2003 and June 2007. The mini-
mum follow-up period for inclusion was six months. 
Preoperative data including age, gender, cause, associated 
conditions, best corrected visual acuity, symptoms, and signs 
were collected. All of the recruited patients were treated by a 
single surgeon (KCY). Informed consent for the procedures 
was obtained from each patient. Institutional review 
board/ethics committee approval was obtained from the 
Chonnam National University Medical School Institutional 
Review Board, and the study protocol followed the guide-
lines of the Declaration of Helsinki.
Ethylenediaminetetraacetic acid chelation
After instillation of topical proparacaine (Alcaine; Alcon, 
Fort Worth, TX, USA), the corneal epithelium overlying 
calcium plaques was removed with a spatula or cotton-
tipped applicator. A cellulose sponge soaked in EDTA (0.05 
M) was applied on the band for 3 to 5 minutes, depending 
on the density of the calcium. After the EDTA had ad-
equately infiltrated into the lesion, the calcium deposits 
were rubbed off. 
Excimer laser phototherapeutic keratectomy
Excimer laser PTK was performed to remove remaining 
calcium plaques in the anterior stroma after EDTA chela-
tion using a Technolas 217z Zyopticx
TM (Bausch & Lomb, 
Feldkirchen, Germany) excimer laser system with an aver-
age energy density of 120 mJ/cm
2 and a pulse repetition rate 
of 50 Hz. The central ablation zone was 7.0-7.5 mm in di-
ameter and 40-50 μm in depth, depending on the extent of 
the lesion. After central ablation, the peripheral cornea was 
ablated with a diameter of 2.0 mm for removal of the re-
maining calcium deposits.
Preparation and preservation of the human amniotic 
membrane 
Preparation and preservation of the AM were performed as 
previously described [12-14,18,19].
 The human placenta was 
obtained, with consent, after an elective cesarean section 
from donors that were seronegative for infectious diseases, 
such as human immunodeficiency virus, hepatitis B and C vi-
rus, and syphilis. The amnion was separated from the rest of 
the chorion by blunt dissection and was cleaned of the re-
maining blood clots with a sterile balanced salt solution 
(Alcon, Fort Worth) containing 50 ng/mL penicillin, 50 
mg/mL streptomycin, 100 ng/mL neomycin, and 2.5 mg/mL 
amphotericin B. After cleansing, the amnion was flattened 
onto 0.45 μm nitrocellulose filter paper with the epithelium 
and basement membrane surface up and was stored at -80℃ 
in a medium containing Dulbecco’s modified Eagle medium 
(GIBCO BRL, Grand Island, NY, USA) and glycerol (Baxter 
Healthcare Corporation, Deerfield, IL, USA) until use.
Amniotic membrane transplantation
EDTA chelation and excimer laser PTK were followed by 
AMT. Under local anesthesia, the preserved AM was cut to 
approximately 8.0 mm in diameter using a trephine blade and 
was placed over the epithelial defect as a graft, with the stro-
mal side facing down. The AM was fixed onto the corneal 
surface using fibrin glue (Greenplast
®; Green Cross, Seoul, 
Korea). Postoperatively, all patients were treated with topical 
ofloxacin (Ocuflox
®; Samil, Seoul, Korea) and fluorometholone 
(Ocumetholone
®, Samil) eyedrops four times a day and hya-
luronic acid (Hyalein
®; Santen, Osaka, Japan) frequently until 
epithelialization was complete and the ocular surface was stable.
Postoperative management and evaluation of results
Follow-up examinations were performed daily for two 
weeks postoperative, and thereafter at 1-2 week intervals. We 
analyzed visual acuity, symptom improvement, healing time 
for epithelial defects, cosmetic results, recurrence, and com-
plications at the last follow-up visit. The cosmetic results 
were divided into three grades: good (clear cornea), fair (mild 
haze, but acceptable cosmesis), and poor (moderate to severe 
haze). Wilcoxon’s rank sum test was used to assess changes 
in visual acuity pre- and postoperatively.
Results
Patient characteristics are presented in Table 1. Of the ten pa-
tients (11 eyes) with BK, two were men and eight were 
women. The mean age was 50.3±21.0 years (range, 17 to 81 
years), and the mean duration of follow-up was 11.4±6.1 
months (range, 6 to 23 months). The causes of BK were prior 
retinal surgery using silicone oil in four eyes (36.4%), glau-
coma in three eyes (27.3%), hypercalcemia in two eyes 
(18.2%), trauma in one eye (9.1%), and idiopathic in one eye 
(9.1%). Preoperatively, all patients had visual disturbances, 
foreign body sensation, and tearing, and one patient had pho-
tophobia.
Postoperatively, the best corrected visual acuity remained 
unchanged in eight eyes (72.7%) and improved in three eyes SK Im, et al. Combined treatment of band keratopathy
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Table 1. Characteristics of patients with band keratopathy and treatment results after ethylenediaminetetraacetic 



















1 45 F Idiopathic 20/1000 20/120 Yes 4 Good No No 23
2 62 M Hypercalcemia 20/30 20/22 Yes 6 Good No No 8
3 62 M Hypercalcemia 20/30 20/28 Yes 4 Good No No 6
4 32 F Trauma LP LP Yes 14 Good No No 7
5 58 F Silicone eye LP LP Yes 14 Fair No No 12
6 56 F Silicone eye HM HM Yes 7 Good No No 12
7 27 F Silicone eye HM HM Yes 11 Good No No 6
8 81 F Glaucoma LP LP Yes 15 Fair No No 17
9 34 F Silicone eye HM HM Yes 13 Fair No No 8
10 17 M Glaucoma, 
uveitis
LP LP Yes 8 Good No No 20
11 79 F Glaucoma 20/1000 20/1000 Yes 21 Good No No 6
BCVA=best corrected visual acuity; LP=light perception; HM=hand movement.
Fig. 1. Pre- and postoperative slit lamp photographs of a patient with band keratopathy who underwent combined ethylene diamine tetraacetic 
acid chelation, phototherapeutic keratectomy, and permanent amniotic membrane transplantation. (A) Preoperatively, extensive calcium depo-
sition with an irregular surface was detected in the central cornea. (B) Two weeks after surgery, the amniotic membrane was well attached to 
the cornea. (C) Six months after surgery, the corneal surface was smooth and stable with mild stromal opacity and neovascularization at the 
inferior cornea. 
(27.3%). There was no significant difference between the 
preoperative and postoperative best corrected visual acuities 
(p=0.11). Symptoms were noticeably improved in all patients. 
The mean time for complete healing of the cornea was 
10.6±5.3 days after surgery: 8 to 14 days in five eyes (45.5%), 
seven days or less in four eyes (36.4%), and 15 days or more 
in two eyes (18.2%). The cosmetic results were good in eight 
eyes (72.7%) and fair in three eyes (27.3%). 
Calcium plaques were removed completely in all cases. 
Although we performed sutureless AM transplantations us-
ing fibrin glue, there were no early detachments of the AM. 
There were no recurrences or complications associated with 
the surgery during the follow-up period. At the last visit, a 
good corneal state was established in all patients (Fig. 1). 
However, in one patient with glaucoma (patient 8), eviscera-
tion was required because of uncontrolled intraocular pres-
sure at postoperative month 17. 
Discussion
The goals of surgical treatment for BK are to provide a 
regular surface and a clear cornea, as well as to improve oc-
ular comfort by removal of calcific deposits and correction 
of surface instability. Various methods have been used in 
the treatment of BK, including EDTA chelation, diamond 
burr, superficial keratectomy, Nd:YAG laser, and PTK 
[3-5,7,8,20-22].
Calcium removal by EDTA chelation is by far the most 
widely used method [3-5,7,8,20-22].
 Najjar et al. [3] reported 
partial or complete symptomatic relief and impro- vement by 
two or more lines of visual acuity after EDTA chelation in 
90% and 33% of patients, respectively.
 Bec- ause treatment 
using EDTA mainly focuses on the removal of calcium pla-
ques in the epithelial layer, the removal of deeply impacted 
calcium deposits in the stromal layer is difficult to achieve 
using this method [4,7,18,19,21].
 When the calcium plaques 
are thick or deeply positioned, the procedure is performed 
mainly to improve ocular co- mfort, not to improve vision; in 
this case, the recurrence rate is higher than that for other 
treatment procedures [3-5,19]. Moreover, calcium plaques 
resistant to EDTA may remain after treatment, causing an ir-
regular corneal surface [7]. Therefore, EDTA chelation has Korean J Ophthalmol Vol.24, No.2, 2010
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the limitation of requiring additional procedures, such as 
PTK [5,19].
PTK has been used effectively for various superficial cor-
neal disorders, such as recurrent corneal erosion, corneal 
opacity, and bullous keratopathy [9,10].
 The indiscriminate 
ablative action of PTK that removes the corneal surface in-
volving the superficial stroma is useful for treatment of BK 
with deeply situated calcium plaques and for restoring a reg-
ular surface [7,8].
 O’Brart et al. [7]
 reported improvement of 
symptoms in 95% of patients and of visual acuity in 88% of 
patients with smooth-band keratopathy after PTK.
 Stewart 
and Morrell [8] also reported that symptoms were relieved in 
83% of the nonvisual group and visual acuity improved or re-
mained unchanged in 55% of the visual group after excimer 
laser PTK.
 However, several complications with PTK have 
been reported, including severe pain from the healing of the 
epithelium and variable refractive changes [7,8].
AMT has recently been performed to complement conven-
tional treatments for BK [18,19]. Many previous studies have 
reported on the beneficial  properties of AM that facilitate 
corneal epithelialization and suppress ocular surface in-
flammation and opacity, both in vivo and in vitro [11,17]. AM 
can protect stromal defects by replacing the removed base-
ment membrane and stroma after superficial keratectomy or 
excimer laser PTK, resulting in a decrease in surgically-in-
duced pain, corneal haze, neovasculariza- tion, and apoptosis 
[16,19]. Anderson et al. [18] perfor- med AMT after surgical 
removal of calcific deposits with or without the use of EDTA 
in 16 eyes of 15 patients with BK.
 Symptoms resolved in all 
cases, and epithelialization was achieved in 93.7% of cases 
with a mean healing time of 15.2 days. Visual acuity im-
proved in 44% and remained unchanged in 56%. Kwon et al. 
[19] treated two patients with AMT following EDTA chela-
tion and superficial lamellar keratectomy.
 They reported that 
complete re-epithelialization was achieved in 9-10 days 
without any symptoms, complications, or recurrence. 
Our strategy for the treatment of BK consists of the co- 
mbination of three techniques: EDTA chelation and excimer 
laser PTK followed by AMT. In the present study, complete 
healing of corneal defects was achieved in all patients with a 
mean time of 10.6±5.3 days after surgery. This healing time 
is satisfactory considering that the corneal defects after PTK 
were deep to the anterior stroma in our patients. Symptoms 
such as pain, foreign body sensation, tearing, and photo-
phobia noticeably improved in all cases without complica-
tions or recurrences during the follow-up period. Best cor-
rected visual acuity improved in the 27.3% of patients that 
had systemic diseases or an idiopathic cause, whereas it re-
mained unchanged in the 72.7% that had associated ocular 
diseases. Consistent with previous reports, this finding sug-
gests that postoperative visual acuity may not improve with 
BK caused by concurrent ocular pathology, despite treatment 
[8,18,21].
 Sp- herical equivalents could not be measured pre-
operatively because of thick calcium depositions at the ante-
rior stroma, and so no data about refractive changes after PTK 
were available. The cosmetic results were generally satisfactory. 
We performed a sutureless AM surgery using fibrin glue. 
This procedure has several advantages, including low-grade 
irritation and scar formation, a low frequency of graft loss by 
atrophic changes, and a shorter operation time compared to 
that of the suture techniques [23,24].
 In addition, the techni-
que does not require suture removal after surgery. Our com-
bined approach for the treatment of BK has drawbacks of a 
longer operation time and greater expense. However, the 
combined procedure can prevent additional costs and time 
spent on reoperation due to recurrent lesions. That we saw no 
recurrence in our study may be explained by two factors: 
first, compared with previous reports [3], the mean follow-up 
period in this study was shorter. Second, in contrast to single 
procedures [3,7], the combined procedure may inhibit lesion 
recurrence [19]. In the future, a long term follow-up study 
with a large sample size will be needed. 
In conclusion, because of the limitations of conventional 
techniques, we suggest that a combined treatment of EDTA 
chelation and PTK followed by AMT using fibrin glue for 
deeply situated calcium deposits in band keratopathy can in-
duce symptom relief, reduce healing time, and prevent 
recurrence. Therefore, the combined procedure can be a safe 
and reliable approach to manage band keratopathy. Further 
studies with a prospective randomized design and a larger 
sample size with a control group are needed.
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